EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant Chemotherapy With Paclitaxel, Carboplatin, and Cetuximab for Locally Advanced Head and Neck Cancer

Takuma Matoba, Daisuke Kawakita, Kiyoshi Minohara, Sho Iwaki, Koji Tsukamoto, Michi Sawabe, Gaku Takano, Hiroshi Tsuge, Sae Imaizumi, Keiichiro Shingaki, Tomota Kamida, Satsuki Nakano und 2 weitere

Anticancer Research · 2026-07 · 46 (7) · 4031-4043

DOI: 10.21873/anticanres.18263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.06.2026. Verfasst von Takuma Matoba und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Hauptthemen laut MEDLINE: Carboplatin, Cetuximab, Neoadjuvant Therapy, Paclitaxel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarboplatinCetuximabNeoadjuvant TherapyPaclitaxelAntineoplastic Combined Chemotherapy ProtocolsHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckHumansFemaleMaleAgedMiddle AgedRetrospective StudiesAdultDisease-Free Survival

Stichwörter der Autor:innen

Head and neck squamous cell carcinomaand cetuximabcarboplatinneoadjuvant chemotherapypaclitaxelpathological responsetumor regression grade

Substanzen

CarboplatinCetuximabPaclitaxel

Autor:innen und Institutionen

  • Department of Otolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Otolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; dk200811@gmail.com.
  • Department of Otorhinolaryngology, Toyota Kosei Hospital, Toyota, Japan.
  • Department of Otorhinolaryngology, Nagoya City University West Medical Center, Nagoya, Japan.
  • Department of Otorhinolaryngology, Kainan Hospital, Yatomi, Japan.
  • Department of Head and Neck Surgery, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.

Zitieren

APA

Matoba, T., Kawakita, D., Minohara, K., Iwaki, S., Tsukamoto, K., Sawabe, M., Takano, G., Tsuge, H., Imaizumi, S., Shingaki, K., Kamida, T., Nakano, S., Murase, T., & Iwasaki, S. (2026). Neoadjuvant Chemotherapy With Paclitaxel, Carboplatin, and Cetuximab for Locally Advanced Head and Neck Cancer. Anticancer Research, 46(7), 4031-4043. https://doi.org/10.21873/anticanres.18263

Vancouver

Matoba T, Kawakita D, Minohara K, Iwaki S, Tsukamoto K, Sawabe M, et al. Neoadjuvant Chemotherapy With Paclitaxel, Carboplatin, and Cetuximab for Locally Advanced Head and Neck Cancer. Anticancer Research. 2026;46(7):4031-4043. doi:10.21873/anticanres.18263

BibTeX
@article{Matoba2026,
  author = {Matoba, Takuma and Kawakita, Daisuke and Minohara, Kiyoshi and Iwaki, Sho and Tsukamoto, Koji and Sawabe, Michi and Takano, Gaku and Tsuge, Hiroshi and Imaizumi, Sae and Shingaki, Keiichiro and Kamida, Tomota and Nakano, Satsuki and Murase, Takayuki and Iwasaki, Shinichi},
  title = {Neoadjuvant Chemotherapy With Paclitaxel, Carboplatin, and Cetuximab for Locally Advanced Head and Neck Cancer},
  journal = {Anticancer Research},
  year = {2026},
  volume = {46},
  number = {7},
  pages = {4031--4043},
  doi = {10.21873/anticanres.18263}
}
Kostenlos starten →